Medindia
Medindia LOGIN REGISTER
Advertisement

Perrigo Reports Record Third Quarter Revenue, All-Time Record Earnings, and Raises Full Year Adjusted EPS Guidance

Friday, April 30, 2010 General News
Advertisement

Table III

FY 2010 GUIDANCE AND FY 2009 EPS

RECONCILIATION OF NON-GAAP MEASURES

(unaudited)

Full Year*

Fiscal 2010 Guidance

FY10 reported diluted earnings per share from continuing operations range

$2.42 - $2.47

  Charges associated with inventory step-ups

0.050

  Charge associated with acquired research and development

0.123

  Charges associated with acquisition costs

0.081

  Charges associated with restructuring

0.078

FY10 adjusted diluted earnings per share from continuing operations range

$2.75 - $2.80

Fiscal 2009*

FY09 reported diluted earnings per share from continuing operations

$1.67

  Loss on asset exchange

0.007

  Charges associated with inventory step-ups

0.021

  Fixed asset impairment

0.011

  Write-off of in-process R&D

0.002

  Investment impairment

0.161

FY09 adjusted diluted earnings per share from continuing operations

$1.87

*All information based on continuing operations.

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close